[43] reported that AXIN1 mutations contribute to the inactivation of the β‐catenin destruction complex, accounting for 8%–10% of alterations in the Wnt/β‐catenin signaling pathway in HCC. The gene discussed is AXIN1; the disease is hepatocellular carcinoma.